Melek Yaman Ortaköylü

Years Active: 2022-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Melek Yaman Ortaköylü, Sonay İncesoy Özdemir, Handan Dinçaslan, Nurdan Taçyıldız, Ufuk Ateş, Ali Ekrem Ünal, Çiğdem Soydal, Ömer Suat Fitöz, Halil Gürhan Karabulut, Hatice Ilgın Ruhi, Emel Cabi Ünal
De novo germline TP53 mutation in a pediatric patient with Li-Fraumeni syndrome and diffuse peritoneal mesothelioma. Pediatric blood & cancer (2024)
Melek Yaman Ortaköylü, Sonay İncesoy Özdemir, Handan Dinçaslan, Nurdan Taçyıldız, Ufuk Ateş, Ali Ekrem Ünal, Çiğdem Soydal, Ömer Suat Fitöz, Halil Gürhan Karabulut, Hatice Ilgın Ruhi, Emel Cabi Ünal
De novo germline TP53 mutation in a pediatric patient with Li-Fraumeni syndrome and diffuse peritoneal mesothelioma. Pediatric blood & cancer 71 (8) (2024)
Melek Yaman Ortaköylü, Sonay İncesoy Özdemir, Handan Dinçaslan, Nurdan Taçyıldız, Ufuk Ateş, Ali Ekrem Ünal, Çiğdem Soydal, Ömer Suat Fitöz, Halil Gürhan Karabulut, Hatice Ilgın Ruhi, Emel Cabi Ünal
De novo germline TP53 mutation in a pediatric patient with Li-Fraumeni syndrome and diffuse peritoneal mesothelioma. Pediatric blood & cancer 71 (8) (2024)
Melek Yaman Ortaköylü, Sonay İncesoy Özdemir, Handan Dinçaslan, Nurdan Taçyıldız, Ali Ekrem Ünal, Çiğdem Soydal, Ömer Suat Fitöz, Emel Ünal
Nivolumab for pediatric malignant peritoneal mesothelioma. Pediatric blood & cancer (2022)

Melek Yaman Ortaköylü.css-eqlu8i{font-size:small;padding-left:4px;}